temperature target of 33°C versus 36°C (ie, avoidance of hyperthermia) (11) . However, this still does not explain the excess mortality associated with therapeutic hypothermia observed in the Mourvillier et al (6) study. One may speculate as to whether potential benefits of induced hypothermia on neuroprotection may be countered by excess risks for other complications. While Mourvillier et al (6) did not observe excess non-neurological complications associated with hypothermia treatment, a significant body of literature exists supporting the major adverse effects of hypothermia on outcome of critically ill patients (12) (13) (14) . One mechanism to explain this effect is that hypothermia is immune suppressive and clearly increases the risk for development of infections in patients admitted to ICUs (15, 16) .
While these data support the maintenance of normothermia in patients with meningitis, these results may not be generalizable to management of patients with severe infections who do not have neurological impairment. Indeed, in the absence of neurological compromise, there are several theoretical benefits to elevated body temperature. Fever is an evolutionary, adaptive response to infection and its presence inhibits growth of microorganisms, may reduce the expression of virulence factors, increases antimicrobial susceptibility and enhances immune responses (17) . While complex, with many variables related to individual patient characteristics, the body of observational data involving >500,000 patients suggests that mild to moderate fever is associated with a better outcome than normothermia, especially among infected patients (18, 19) . Clinical trials evaluating fever control strategies have not demonstrated overall benefit in neurologically intact patients in the ICU (20, 21) , with suggestion for potential harm observed in one study (22) . It is somewhat curious, therefore, that collectively as clinicians, we have come to recognize fever as a pathological state that requires prompt pharmacological and physical correction. Surveys conducted around the globe indicate that ≥80% of clinicians report the need to treat even mild to moderate fever most or all of the time; however, such a practice is not supported or potentially even contrary to available evidence (23, 24) .
summary
We believe that the study by Mourvillier et al (6) is an important addition to the infectious diseases literature and serves to guide our management of patients with severe meningitis. Based on this study and others, it is evident that hypothermia is a pathological state and prompt resuscitation to normothermia is warranted in patients with severe infections. In contrast, fever is an adaptive host response to infection and its presence is associated with improved outcome in neurologically intact, infected patients admitted to ICUs. While it may appear ridiculous to the many clinicians who insist on treating all fevers in infected patients, it is our contention that therapeutic hyperthermia requires (re-)exploration as an adjunctive therapy for selected patients with infection (25) .
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